• Fulcrum Therapeutics held its annual shareholder meeting on June 24, 2026.
• Shareholders elected Sonja Banks, Alan Ezekowitz, Colin Hill to the board.
• An advisory vote on executive officer pay passed.
• Ernst & Young was ratified as independent auditor for fiscal 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fulcrum Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-282873), on June 25, 2026, and is solely responsible for the information contained therein.